welcome to japan’s regenerative1 fujifilm corporation firm (forum for innovative regenerative...
TRANSCRIPT
1
FUJIFILM Corporation
FIRM (Forum for Innovative Regenerative Medicine) Head, Steering Committee
Takuya Yokokawa
18nd March, 2016
Welcome to Japan’s Regenerative Medicine Market
2
About FIRM Established on June 17, 2011
To accelerate Industrialization Regenerative Medicine in Japan
Machinery・Device
35
Chemical・Material
45
Regenerative Medicine・Cell Therapy Bio-technology 45 Pharmaceutical
Logistics・Insurance・Consulting etc.
60
FIRM members – 185 companies (January. 2016)
General Meeting
Board of Directors
Auditors
Secretariat
Committees for National/Public
Projects
Supporting Industries Committee
Council for Steering Committee
Steering Committee
Regenerative Medicine Industrialization
Task Force
ISO/TC276
Japan Mirror Committee
Regulatory Committee
Educational Affairs Committee
Ethical & Compliance Committee
International Affairs Committee
Publication Committee
Business & Public Affairs Committee
Medical Economics Committee
Standardization Committee
Regulatory Affairs Committee
Management Committees Expert Committees
Organization of FIRM
4
“Life Innovation Center”(LIC)
4
【Lot】
■Lot size：8,000m
■Landowner：
Kanagawa Prefectural
government
【Building】
■Use：Laboratory
■Structure：
4 floors
above the ground ■Total floor space：
16,000m
2
2
2015.10
2015.12
2015.3
Canada （CCRM 1)）
USA
（ARM 2)）
Australia （Embassy of Australia）
Asia
United Kingdom （BIA ３)）
Sweden （Embassy of Sweden）
Global Network of FIRM
1) CCRM： Center for Commercialization of Regenerative Medicine
2) ARM： Alliance for Regenerative Medicine
3) BIA： BioIndustry Association 5
2016.2
(2016.3)
Industrialization Support Team Business Office @ Downtown Tokyo
RMIT [email protected]
http://firm.or.jp/en/en_rmit
Entities interested in Regenerative Medicine
industrialization FIRM member companies
Requests, inquiries, etc.
Response & discussion
Discussion with applicable companies
Partnering
Collaboration
Regenerative Medicine Industrialization Task Force (RMIT) FIRM initiative newly established task force for fostering
Regenerative Medicine Development in Japan.
6
Business office
Conclusion
1.Regenerative Medicine Market in Japan is attractive.
2.To maximize opportunity, Japanese industries welcome foreign companies for collaboration in a lot of business sectors.
3.FIRM is a hub of collaboration. Please contact Regenerative Medicine Industrialization Task Force (RMIT) in FIRM.
7
8
http://www.firm.or.jp/en/en_rmit
Contact to
Regenerative Medicine Industrialization Task Force (RMIT)
Thank you for your attention